ijms-logo

Journal Browser

Journal Browser

Molecular Research in Allergic Diseases 2.0

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Endocrinology and Metabolism".

Deadline for manuscript submissions: closed (30 April 2022) | Viewed by 5817

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pharmacy, University of Naples Federico II, 80138 Naples, Italy
Interests: airway function; inflammatory lung diseases; sphingolipid metabolism; lipid mediators
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Over the last years bioactive lipids have emerged as clinically-relevant mediators of allergic disease pathophysiology. Compelling evidence suggests the importance of lipid mediators in the development of asthma, allergic rhinitis, atopic dermatitis, anaphylaxis, and food allergy. Lipids play key roles in cell signaling events, influencing physiologic (bronchial tone) and immune mechanisms (degranulation, chemotaxis, and sensitization) in allergic diseases. Lipids act through several cellular mechanisms such as the formation of structural support platforms (lipid rafts) for receptor signaling complexes, the activation of a diverse family of G-protein coupled receptors, and the mediation of intracellular signaling cascades by acting as second messengers. An increased understanding of these critical bioactive molecules will drive future innovations in treating atopy in its many forms. This Special Issue aims to shed light on and further the understanding of some of these intricate signaling mechanisms in allergic diseases. Specifically, we propose to explore and discuss the following points: (1) lipid synthesis pathways and signaling in atopic disease pathology; (2) the development of allergic disease treatments targeting lipid mediator pathways

Prof. Fiorentina Roviezzo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • atopy
  • asthma
  • immune inflammation
  • sphingolipid
  • leukotrienes
  • anaphylaxis
  • therapeutic targets
  • food allergy

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

22 pages, 12855 KiB  
Article
Evaluating the Protective Properties of a Xyloglucan-Based Nasal Spray in a Mouse Model of Allergic Rhinitis
by Marika Lanza, Giovanna Casili, Alessia Filippone, Michela Campolo, Irene Paterniti, Salvatore Cuzzocrea and Emanuela Esposito
Int. J. Mol. Sci. 2021, 22(19), 10472; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms221910472 - 28 Sep 2021
Cited by 6 | Viewed by 2052
Abstract
A breached nasal epithelial barrier plays an important role in driving allergic rhinitis (AR). Corticosteroids remain the standard of care (SoC) but come with side effects, thus alternative safe and effective treatments able to avoid inflammation and restore barrier integrity are needed. The [...] Read more.
A breached nasal epithelial barrier plays an important role in driving allergic rhinitis (AR). Corticosteroids remain the standard of care (SoC) but come with side effects, thus alternative safe and effective treatments able to avoid inflammation and restore barrier integrity are needed. The aim of the present study is to evaluate the barrier-forming capacity of a xyloglucan-based nasal spray (XG) and compare its efficacy to several SoC treatments (corticosteroid spray, oral mast-cell stabilizer and oral antihistamine) in reducing allergic responses in addition to its effect when concomitantly administered with an antihistamine. An ovalbumin (OVA)-induced mouse AR model was used. XG shows a significant efficacy in reducing histological damage in AR mice; improves nasal rubbing and histamine-induced hyper-responsiveness. Total and OVA-specific IgE as well as pro-inflammatory cytokines are significantly reduced compared to OVA challenged-mice, with im-proved efficacy when used as an add-on treatment. However, XG reduces mucous secreting cells (PAS-positive) and mucin mRNA expression similar to the corticosteroid-treated mice. XG-spray maintains tight junction protein expression (ZO-1) and conversely decreases HDAC1 significantly; the latter being highly expressed in AR patients. Moreover, the concomitant treatment showed in all of the endpoints a similar efficacy to the corticosteroids. This innovative approach may represent a novel therapeutic strategy for nasal respiratory diseases like AR, reducing undesirable side effects and improving the quality of life in patients. Full article
(This article belongs to the Special Issue Molecular Research in Allergic Diseases 2.0)
Show Figures

Figure 1

Review

Jump to: Research

21 pages, 1117 KiB  
Review
Current Insights on the Impact of Proteomics in Respiratory Allergies
by Juan Carlos Vizuet-de-Rueda, Josaphat Miguel Montero-Vargas, Miguel Ángel Galván-Morales, Raúl Porras-Gutiérrez-de-Velasco and Luis M. Teran
Int. J. Mol. Sci. 2022, 23(10), 5703; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms23105703 - 20 May 2022
Cited by 3 | Viewed by 3201
Abstract
Respiratory allergies affect humans worldwide, causing extensive morbidity and mortality. They include allergic rhinitis (AR), asthma, pollen food allergy syndrome (PFAS), aspirin-exacerbated respiratory disease (AERD), and nasal polyps (NPs). The study of respiratory allergic diseases requires new technologies for early and accurate diagnosis [...] Read more.
Respiratory allergies affect humans worldwide, causing extensive morbidity and mortality. They include allergic rhinitis (AR), asthma, pollen food allergy syndrome (PFAS), aspirin-exacerbated respiratory disease (AERD), and nasal polyps (NPs). The study of respiratory allergic diseases requires new technologies for early and accurate diagnosis and treatment. Omics technologies provide the tools required to investigate DNA, RNA, proteins, and other molecular determinants. These technologies include genomics, transcriptomics, proteomics, and metabolomics. However, proteomics is one of the main approaches to studying allergic disorders’ pathophysiology. Proteins are used to indicate normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. In this field, the principal goal of proteomics has been to discover new proteins and use them in precision medicine. Multiple technologies have been applied to proteomics, but that most used for identifying, quantifying, and profiling proteins is mass spectrometry (MS). Over the last few years, proteomics has enabled the establishment of several proteins for diagnosing and treating respiratory allergic diseases. Full article
(This article belongs to the Special Issue Molecular Research in Allergic Diseases 2.0)
Show Figures

Figure 1

Back to TopTop